Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)

Condition:   Hemophilia B Intervention:   Genetic: AAV5-hFIXco-Padua Sponsor:   CSL Behring Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials